Table 1 Treatment assignment and compliance.
Sequence A SAMe – Celecoxib | Sequence B Celecoxib – SAMe | |
|---|---|---|
Subjects Randomized to each arm | 30 | 31 |
PHASE 1 | SAMe | Celecoxib |
Subjects receiving treatment | 29 | 30 |
Subjects Completing Phase 1 | 28 | 29 |
PHASE 2 | Celecoxib | SAMe |
Subjects receiving treatment | 28 | 29 |
Subjects Completing Phase 2 | 27 | 29 |